These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 8723506)

  • 21. Future of nuclear medicine--impact of new radiopharmaceuticals and of alternative methods such as nuclear magnetic resonance.
    Pfannenstiel P; Rinck PA
    Nuklearmedizin; 1984 Dec; 23(6):273-6. PubMed ID: 6335745
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Techniques for Loading Technetium-99m and Rhenium-186/188 Radionuclides into Preformed Liposomes for Diagnostic Imaging and Radionuclide Therapy.
    Goins B; Bao A; Phillips WT
    Methods Mol Biol; 2017; 1522():155-178. PubMed ID: 27837538
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An alternate approach to the production of radioisotopes for nuclear medicine applications.
    D'Auria JM; Keller R; Ladouceur K; Lapi SE; Ruth TJ; Schmor P
    Rev Sci Instrum; 2013 Mar; 84(3):034705. PubMed ID: 23556835
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The production of radionuclides for nuclear medicine from a compact, low-energy accelerator system.
    Webster WD; Parks GT; Titov D; Beasley P
    Nucl Med Biol; 2014 May; 41 Suppl():e7-15. PubMed ID: 24434013
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neutron-activated theranostic radionuclides for nuclear medicine.
    Tan HY; Yeong CH; Wong YH; McKenzie M; Kasbollah A; Md Shah MN; Perkins AC
    Nucl Med Biol; 2020; 90-91():55-68. PubMed ID: 33039974
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Unconventional nuclides for radiopharmaceuticals.
    Holland JP; Williamson MJ; Lewis JS
    Mol Imaging; 2010 Feb; 9(1):1-20. PubMed ID: 20128994
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The bright future of radionuclides for cancer therapy.
    Nijsen JF; Krijger GC; van Het Schip AD
    Anticancer Agents Med Chem; 2007 May; 7(3):271-90. PubMed ID: 17504155
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular medicine: from science to service.
    Wagner HN
    J Nucl Med; 1991 Aug; 32(8):11N-12N, 14N-16N, 17N-23N. PubMed ID: 1869963
    [No Abstract]   [Full Text] [Related]  

  • 29. Sustained availability of 99mTc: possible paths forward.
    Pillai MR; Dash A; Knapp FF
    J Nucl Med; 2013 Feb; 54(2):313-23. PubMed ID: 23255729
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Radionuclides in the management of thyroid cancer.
    Buscombe JR
    Cancer Imaging; 2007 Dec; 7(1):202-9. PubMed ID: 18083649
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ARRONAX, a high-energy and high-intensity cyclotron for nuclear medicine.
    Haddad F; Ferrer L; Guertin A; Carlier T; Michel N; Barbet J; Chatal JF
    Eur J Nucl Med Mol Imaging; 2008 Jul; 35(7):1377-87. PubMed ID: 18465127
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Radionuclide-labeled red blood cells: current status and future prospects.
    Srivastava SC; Chervu LR
    Semin Nucl Med; 1984 Apr; 14(2):68-82. PubMed ID: 6233700
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PAMAM Dendrimer-Based Nanodevices for Nuclear Medicine Applications.
    Xiao T; Li D; Shi X; Shen M
    Macromol Biosci; 2020 Feb; 20(2):e1900282. PubMed ID: 31829523
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Radiation dose to technicians per nuclear medicine procedure: comparison between technetium-99m, gallium-67, and iodine-131 radiotracers and fluorine-18 fluorodeoxyglucose.
    Chiesa C; De Sanctis V; Crippa F; Schiavini M; Fraigola CE; Bogni A; Pascali C; Decise D; Marchesini R; Bombardieri E
    Eur J Nucl Med; 1997 Nov; 24(11):1380-9. PubMed ID: 9371871
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Which radionuclides will nuclear oncology need tomorrow?
    Barbet J; Chatal JF; Gauché F; Martino J
    Eur J Nucl Med Mol Imaging; 2006 Jun; 33(6):627-30. PubMed ID: 16741760
    [No Abstract]   [Full Text] [Related]  

  • 36. Operational radiation safety for PET-CT, SPECT-CT, and cyclotron facilities.
    Zanzonico P; Dauer L; St Germain J
    Health Phys; 2008 Nov; 95(5):554-70. PubMed ID: 18849690
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Nuclear medicine: current aspects and future].
    Fridrich R; Müller-Brand J
    Schweiz Med Wochenschr Suppl; 1988; 25():17-29. PubMed ID: 3041577
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Operational nuclear research reactors in the Asia-Pacific with potential for medical radionuclide production.
    Tan HY; Wong YH; Kasbollah A; Md Shah MN; Perkins AC; Yeong CH
    Nucl Med Commun; 2023 Apr; 44(4):227-243. PubMed ID: 36808108
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nanotargeted radionuclides for cancer nuclear imaging and internal radiotherapy.
    Ting G; Chang CH; Wang HE; Lee TW
    J Biomed Biotechnol; 2010; 2010():. PubMed ID: 20811605
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nuclear medicine.
    Alazraki NP
    JAMA; 1995 Jun; 273(21):1697-8. PubMed ID: 7752423
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.